AbbVie announced that for the tenth consecutive year, it has been named to the Dow Jones Sustainability World Index  and Dow Jones Sustainability North America Index. Additionally, AbbVie achieved the highest score in the biotech sector on the 2022 S&P Global Corporate Sustainability Assessment (CSA). Since AbbVie’s founding in 2013, the company has been listed on the DJSI World and DJSI North America every year.

“As part of being a company built on sustainable practices, we are committed to taking actions that best serve patients, our employees, communities and the planet,” said Claudia Carravetta, vice president of corporate responsibility and global philanthropy, AbbVie. “We are proud to be included on this year’s Dow Jones Sustainability World Index and to have achieved the highest score in the biotech industry.”

Across this year’s S&P Global CSA, AbbVie received top scores in the biotech sector in the following nine criterion:

• Environmental Dimension: Environmental Reporting
• Social Dimension: Social Reporting, Human Rights, Human Capital Development, Talent Attraction & Retention and Access to Healthcare
• Governance & Economic Dimension: Materiality, Tax Strategy and Risk & Crisis Management